Pediatric Inflammatory Multisystem Syndrome: Time to Collaborate

Hari Krishnan Kanthimathinathan; Barnaby R Scholefield

doi:10.1093/jpids/piaa105

Pediatric Inflammatory Multisystem Syndrome: Time to Collaborate

J Pediatric Infect Dis Soc. 2021 Apr 3;10(3):227-229. doi: 10.1093/jpids/piaa105.

Authors

Hari Krishnan Kanthimathinathan^{1

2}, Barnaby R Scholefield^{1

3}

Affiliations

¹ Paediatric Intensive Care Unit, Birmingham Women's and Children's National Health Service Foundation Trust, Birmingham, United Kingdom.
² Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom.
³ Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.

Abstract

There is significant variability in the names and case definition of pediatric inflammatory multisystem syndrome associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Such variability leads to adverse consequences in the quest for further knowledge and management strategies. It is time to collaborate to gain consensus.

Keywords: COVID-19; Kawasaki disease; SARS-CoV-2; coronavirus; multisystem inflammatory syndrome.

© The Author(s) 2020. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

MeSH terms

Adolescent
COVID-19 / pathology*
COVID-19 / virology
Child
Child, Preschool
Humans
Infant
Infant, Newborn
Mucocutaneous Lymph Node Syndrome / pathology
Mucocutaneous Lymph Node Syndrome / virology
SARS-CoV-2 / isolation & purification
Systemic Inflammatory Response Syndrome / pathology
Systemic Inflammatory Response Syndrome / virology*

Supplementary concepts

pediatric multisystem inflammatory disease, COVID-19 related